Breadcrumbs Home News & Events Press Releases Press Releases Year All2026202520242023202220212020201920182017201620152014201320122011201020092008 Type AllRegulatoryNon-regulatory Jul 01, 2020 BioInvent extends research collaboration and license agreement with Pfizer Inc. Jun 30, 2020 BioInvent submits a CTA for a Phase I/IIa trial of BI-1808, a first-in-class anti-TNFR2 antibody for the treatment of patients with solid tumors and CTCL Jun 30, 2020 Change in the number of shares and votes in BioInvent International AB Jun 23, 2020 BioInvent enrolls first patient in Phase I/IIa trial of BI-1206 in combination with KEYTRUDA[®] for the treatment of patients with solid tumors Jun 22, 2020 BioInvent presents proof-of-concept data for two TNFR2-targeting antibodies Jun 22, 2020 BioInvent and Transgene's BT-001 achieves outstanding tumor cure rates in preclinical models Pagination First page Previous page … Page 37 Current page 38 Page 39 Page 40 … Next page Last page
